Chronic adverse effects from anti-PD-1 immunotherapies common
(HealthDay)—Chronic immune-related adverse effects after adjuvant treatment with anti-programmed cell death 1 (anti-PD-1) immunotherapies for melanoma are more common than previously thought, according to a study published ...
Apr 16, 2021
0
3